Discussion: Treatment of Neurocognitive Disorders:Mild Cognitive Impairment

To prepare for this Discussion:

  • By Day 5 of Week 7, your Instructor will have assigned you a neurocognitive disorder,( Mild Cognitive Impairment)which will be the focus for your initial post for this Discussion.
  • Review the Learning Resources.

Post:

  • Explain the diagnostic criteria for your assigned neurocognitive disorder.
  • Explain the evidenced-based psychotherapy and psychopharmacologic treatment for your assigned neurocognitive disorder.
  • Identify the risks of different types of therapy and explain how the benefits of the therapy that might be achieved might outweigh the risks.
  • Support your rationale with references to the Learning Resources or other academic resource.

Required Readings

Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadockâ€s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer.

  • Chapter 21, “Neurocognitive Disorders†(pp. 694–741)

Gabbard, G. O. (2014). Gabbardâ€s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications.

  • Chapter 63, “Deliriumâ€
  • Chapter 64, “Neurocognitive Disorder Due to Alzheimerâ€s Diseaseâ€
  • Chapter 65, “Frontotemporal Neurocognitive Disorderâ€
  • Chapter 66, “Vascular Neurocognitive Disorderâ€
  • Chapter 67, “Neurocognitive Disorder Due to Parkinsonâ€s Diseaseâ€

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

  • “Neurocognitive Disordersâ€

Stahl, S. M. (2014). Prescriberâ€s Guide: Stahlâ€s Essential Psychopharmacology (5th ed.). New York, NY: Cambridge University Press.

 

Note: All Stahl resources can be accessed through the Walden Library using the link below. This link will take you to a login page for the Walden Library. Once you log in to the library, the Stahl website will appear. http://ezp.waldenulibrary.org/login?url=http://stahlonline.cambridge.org/

 

To access information on specific medications, click on The Prescriberâ€s Guide, 5th Ed. tab on the Stahl Online website and select the appropriate medication.

 

 

Alzheimer disease Delirium Dementia Parkinsonâ€s disease dementia 

caprylidene donepezil galantamine memantine rivastigmine

haloperidol (adjunct) lorazepam (adjunct) 

donepezil galantamine memantine rivastigmine 

rivastigmine pimavanserin 

 

Note: For more information on Pimavanserin, see:

Acadia Pharmaceuticals. (2017). Transform the treatment of Parkinsonâ€s disease psychosis with NUPLAZID. Retrieved from https://www.nuplazidhcp.com/?gclid=CIHS5auvwtMCFQkaaQodrU0FGQ

U.S. Food and Drug Administration. (n. d.). Highlights of prescribing information: Nuplazid. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207318lbl.pdf

Hopkins, S. A., & Chan, D. (2016). Key emerging issues in frontotemporal dementia. Journal of Neurology, 263(2), 407–413. doi:10.1007/s00415-015-7880-7

Walker, Z., Possin, K. L., Boeve, B. F., & Aarsland, D. (2015). Lewy body dementias. The Lancet, 386(10004), 1683-1697.  

Required Media

Laureate Education (Producer). (2017a). A gentleman with a neurocognitive disorder [Multimedia file]. Baltimore, MD: Author.

 

Bolin, P. (2015, December 31). Neurocognitive disorders – CRASH! Medical review series [Video file]. Retrieved from https://www.youtube.com/watch?v=bQXOPITY9XM

 

Note: The approximate length of this media piece is 57 minutes.

Optional Resources

Kota, L. N., Bharath, S., Purushottam, M., Moily, N. S., Sivakumar, P. T., Varghese, M., . . . Jain, S. (2015). Reduced telomere length in neurodegenerative disorders may suggest shared biology. The Journal of Neuropsychiatry and Clinical Neurosciences, 27(2), e92–e96. doi:10.1176/appi.neuropsych.13100240

Lepkowsky, C. M. (2016). Neurocognitive disorder with Lewy bodies: Evidence-based diagnosis and treatment. Practice Innovations, 1(4), 234–242. doi:10.1037/pri0000031

Oltra-Cucarella, J., Pérez-Elvira, R., Espert, R., & Sohn McCormick, A. (2016). Are cognitive interventions effective in Alzheimerâ€s disease? A controlled meta-analysis of the effects of bias. Neuropsychology, 30(5), 631–652. doi:10.1037/neu0000283

 

. WITH essaylords.us AND GET AN AMAZING DISCOUNT!


Discussion: Treatment of Neurocognitive Disorders:Mild Cognitive Impairment was first posted on April 12, 2020 at 9:56 pm.
©2019 “essaylords.us”. Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at ukbestwriting@gmail.com


Discussion: Treatment of Neurocognitive Disorders:Mild Cognitive Impairment was first posted on April 12, 2020 at 10:16 pm.
©2019 “Essay Lords | Bringing Excellence to students world wide”. Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at support@essaylords.us

BEST-ESSAY-WRITERS-ONLINE

Havent found the Essay You Want?
WE CAN HELP
The Paper is Written from Scratch Specifically for You

Order Now

    WHY CHOOSE courseachievers.com

  • Confidentiality & Authenticity Guaranteed
  • Plagiarism Free answers Guarantee
  • We Guarantee Timely Delivery of All essays
  • Quality & Reliability
  • Papers Written from Scratch and to Your exact Instructions
  • Qualified Writers Only
  • We offer Direct Contact With Your Writer
  • 24/7 Customer Support

GET QUALITY ESSAY WRITING HELP

ORDER A PAPER WRITTEN FROM SCRATCH AND TO YOUR EXACT INSTRUCTIONS

PLACE YOUR ORDER